Dynavax Technologies Corp (NASDAQ:DVAX)

23.06
Delayed Data
As of 12:44pm ET
 +0.36 / +1.59%
Today’s Change
12.50
Today|||52-Week Range
26.89
+36.77%
Year-to-Date

Today’s Trading

Previous close22.70
Today’s open22.87
Day’s range22.55 - 23.62
Volume205,525
Average volume (3 months)422,636
Market cap$656.4M
Dividend yield--
Data as of 12:44pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-3.63%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SCMPSucampo Pharmaceutic...+0.50+3.45%
AMPHAmphastar Pharmaceut...-0.36-2.32%
FLMLFlamel Technologies ...+0.02+0.11%
VTLVital Therapies Inc-0.11-0.45%
Data as of 1:00pm ET, 03/30/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account